Inventor
Thomas Craig Meagher
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes25%
PatentTitleYear
12,319,724IL2 agonists and methods of use thereof202512,291,559Compositions and methods for treating cancer202512,215,131IgG Fc-IL2-Ra-IL2 fusions and methods of use thereof202512,150,959Chimeric antigen receptors with BCMA specificity and uses thereof202412,091,440IL2 and peptide-MHC complex fusion proteins and methods of use thereof202411,826,386Compositions and methods for treating cancer202311,725,034IL2 agonists and methods of use thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to REGENERON PHARMA (7)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 7 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2023–2025 |